[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sanofi (SNY)
Sanofi completes the $XXX billion acquisition of Blueprint Medicines. Emcure Pharmaceuticals partners with Sanofi India to distribute diabetes drugs across India.
About Sanofi
Sanofi (SNY) is a multinational pharmaceutical and healthcare company.
Sanofi uses the ticker $SNY for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- Sanofi (SNY) mentions is at XXX which is XXX% higher than it's daily average.
- Sanofi (SNY) social dominance is up XXXXXX% from the previous week.
- Sanofi (SNY) galaxy score™ is up XXXXX% from the previous week.
- Sanofi (SNY) engagements is up XXXXX% from the previous week.
- Sanofi (SNY) posts created is up XXXXX% from the previous month.
Price: $XXXXX #
Price 24-Hour Chart Data
The price is currently consolidating around $XXXXX. Mixed signals from social media, with strong buy recommendations counterbalanced by vaccine availability concerns, likely explain the price consolidation.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| -XXX% | -XXXX% | XXXX% |
1-Year High: $XXXXX on 2025-03-06
1-Year Low: $XXXXX on 2024-12-16
AltRank: XXX #
AltRank 24-Hour Chart Data
Sanofi (SNY) is currently AltRank #916 based on combined combined social and market metrics
Daily Average: XXXXX
1 Week: XXX +798
1 Month: XXX -XXXXX
6 Months: XXX -XXX
1 Year: XXX -XXX
1-Year High: XXXXX on 2025-07-06
1-Year Low: XXX on 2025-07-07
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +7
6 Months: XX +2
1 Year: XX +2
1-Year High: XX on 2025-07-07
1-Year Low: XX on 2025-07-08
Engagements: XXXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXXXX
1 Week: XXXXXXX +20%
1 Month: XXXXXXXXX -XXXX%
6 Months: XXXXXXXXXX -XX%
1 Year: XXXXXXXXXX -XX%
1-Year High: XXXXXXXXX on 2024-07-31
1-Year Low: XXXXX on 2025-02-02
| Social Network | X | YouTube | TikTok | News | |
|---|---|---|---|---|---|
| Engagements | XXXXXX | XX | XXXXXX | XXX | X |
Mentions: XXX #
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
1 Week: XXXXX -XXXX%
1 Month: XXXXX +48%
6 Months: XXXXXX +18%
1 Year: XXXXXX +38%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2024-08-25
| Social Network | X | YouTube | TikTok | News | |
|---|---|---|---|---|---|
| Mentions | XXX | XX | XXX | XX | X |
Creators: XXX #
Creators 24-Hour Chart Data
XXX unique social accounts have posts mentioning Sanofi (SNY) in the last XX hours which is up XX% from XXX in the previous XX hours
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXXXX +75%
6 Months: XXXXX +17%
1 Year: XXXXX +49%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2025-01-27
The most influential creators that mention Sanofi in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @AponiaAnalytics | X | XXXXX | XX | XXXXX |
| @RupeezyOfficial | X | XXXXXX | X | XXXXX |
| @Trader83117 | X | XX | X | XXX |
| @Quantumup1 | X | XXXXX | X | XXX |
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -X%
6 Months: XX% -X%
1 Year: XX% -X%
1-Year High: XX% on 2024-07-21
1-Year Low: XX% on 2024-11-24
Most Supportive Themes
- Stock Recommendations and Positive Performance: (45%) Positive sentiment surrounds Sanofi's stock, with analysts recommending it based on company performance.
- Novavax Partnership and Vaccine Potential: (20%) Commentary highlights the potential of the Novavax partnership for vaccine distribution.
- Drug Development and Research: (15%) There are mentions of Sanofi's recent developments, collaborations, and studies.
Most Critical Themes
- Vaccine Availability and Supply Chain Issues: (0.1%) Concerns about vaccine availability and supply chain issues are being discussed on social media.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXXX | XX% | XXXXX | XX% |
| XX | X% | XX | X% | X | X% | |
| YouTube | XXXXXX | XX% | XXXXX | X% | XX | X% |
| TikTok | XXX | X% | XXX | X% | XX | X% |
| News | X | X% | X | X% | X | X% |
| Total | XXXXXX | XX% | XXXXXX | XX% | XXXXX | XX% |
Social Dominance: XXXXX% #
Social Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.035%
1 Month: XXXXX% -XXXXX%
6 Months: XXXXX% +0.044%
1 Year: XXXXX% +0.019%
1-Year High: XXXXX% on 2025-03-12
1-Year Low: XXXXX% on 2025-07-12
Market Dominance: XXXXX% #
Market Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXX% on 2024-09-07
1-Year Low: XXXXX% on 2025-07-19
Market Cap: $XXXXXXXXXXXXXXX #
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXXXX -$0.93%
1 Month: $XXXXXXXXXXXXXXX +$1.80%
6 Months: $XXXXXXXXXXXXXXX -$7.20%
1 Year: $XXXXXXXXXXXXXXX -$7%
1-Year High: $XXXXXXXXXXXXXXX on 2025-03-06
1-Year Low: $XXXXXXXXXXXXXXX on 2024-12-16
Top assets mentioned In the posts about Sanofi in the last XX hours
Hims & Hers Health, Inc. (HIMS) Synthetify (SNY) McDonald's Corp (MCD) Accenture (ACN) Regeneron Pharmaceuticals Inc (REGN) Blueprint Medicines Corporation (BPMC) Eli Lilly and Company (LLY) Pfizer, Inc. (PFE) Thermo Fisher Scientific Inc. (TMO)
Top topics mentioned In the posts about Sanofi in the last XX hours
stocks healthcare, manat, $hims, hims, $vani, pfe, india, $zldpf, stocks, coins healthcare, coins ai, investment, abbv, drugs, $mcd, acquisition, $acn, $regn, $bpmc, jnj, $lly, $nkechl, stockmarket, $pfe, $baynsg, $tmo, $jnj, fisher, amzn, united states, $nvax, $nktr, asml, stocks technology, nvda, $apge, eli, france, $mrk, $nvs, novartis, teva, lin, jersey, $crvs, $nvo, $azn, nasdaq, qqq, le, flu, $novnsw, $novcde, $nrix, money, hood, $gsk, $gild, coins energy, ireland, novo, googl, $vigl, baba, careers, spx, tak, #fyp, lvmh, $rhhby, $kymr, corporate finance, msft, $cogt, pltr, regeneron pharmaceuticals inc, $amgn, sap, cvx, seed funding, guinea, $biib, gilead sciences, sec, mcap, $vtyx, approved, qui, life changing, $vrna, market cap, saving, $xbi, gibraltar pound, $vrtx, paris, telo, gamble, spgi, op
Top News #
Top news links shared on social in the last XX hours
Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.
"Sanofi completes $XXX billion acquisition of Blueprint Medicines Nasdaq delisting follows By Investing.com"
@Investingcom on X 2025-07-18 10:32:43 UTC 1.3M followers, XX engagements
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"🦉 For weight loss CagriSema ranked highest with XXXXX kg followed by tirzepatide and retatrutide. Adverse events rose with dose notably GI issues making tolerability a key factor. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #glp1 #diabetes"
@AponiaAnalytics on X 2025-07-19 15:25:41 UTC 4963 followers, XXX engagements
"🦉 Tirzepatide led glycaemic control with a XXXX% HbA1c drop and XXXX mmol/L fasting glucose outperforming XX other GLP-1RAs. Its dose-efficacy was linear peaking at XX mg weekly. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #glp1 #diabetes"
@AponiaAnalytics on X 2025-07-19 15:25:41 UTC 4960 followers, XXX engagements
"💼Comparative effectiveness of GLP-1 receptor agonists on glycaemic control body weight and lipid profile for type X diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #glp1 #diabetes"
@AponiaAnalytics on X 2025-07-19 15:25:40 UTC 4960 followers, XXX engagements
"🦉 Tirzepatide caused more GI issues in trials but delivered stronger weight loss while exenatide had higher nausea and injection site reactions. Liraglutide ranks worst for early nausea at 40%. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1"
@AponiaAnalytics on X 2025-07-19 15:04:42 UTC 4960 followers, XXX engagements